The 13th Annual Miami Myeloma MRD Meeting will take place on 10  April 2026 in Miami, FL where the world’s leading clinical researchers in multiple myeloma will discuss the use of measurable residual disease (MRD) in clinical and trial settings, putting recent advances into context, and encouraging interactive discussion throughout.